Workplace flu vaccinations are a great way to protect your employees.  Together with our partner, Healthworks, we offer on-site flu vaccinations for businesses across Australia and can create a tailored solution to prepare your business for a healthy year.

Influenza in 2023

Influenza, also known as the flu, can have a powerful effect on an organisation and their workers’ health, attributing to high rates of absenteeism and lower rates of productivity throughout the business annually. That’s why it is important to start planning early so you can protect your workplace from the flu. 

Together with our partner, Healthworks, we can create a tailored solution to prepare your business for the 2023 flu season and ensure that your employees are fit and healthy all year round.

The Effect of Flu on your Business

Each year, the flu costs Australian businesses more than $2 billion, with an estimated 1,500,000 work days lost each year due to the illness. Unlike a cold, the flu can last for a week or more and individuals can feel fatigue for a period of two to three weeks.

The influenza virus is also highly contagious, with the infection transferring from person to person before noticeable symptoms are present. Prevention through an annual onsite vaccination program can be the key to keeping your workforce healthy.

Corporate Flu Vaccinations

When you implement your employee flu vaccination program, a specialist immunisation nurse will attend your workplace to provide the influenza vaccine to workers onsite. A corporate flu vaccination program is one of the easiest programs to incorporate into your business. It only takes a few minutes out of an employees’ work day and in return, the business reaps long term positive effects associated with employee health costs.

The health and wellbeing division of our business, Healthworks, partner with Australia Vaccine Services (AVS) to provide you with highly experienced end-to-end project management, along with fully qualified and insured immunisation nurses who have completed over 395,000 vaccinations in the last 5 years. Our team is able to work with the unique needs of your organisation to provide a fully customisable service nationally.

Once booked, our specialised immunisation team will administer the 2023 flu vaccinations to your employees in a professional and efficient manner. We also provide off-site flu shots if any staff who are unable to attend on the day of the vaccination program.

The Benefit of Corporate Flu Shots

Influenza vaccination can prevent illness in about 50–60% of young children and healthy adults under the age of 65 years, although this figure varies year by year.

The flu vaccine and corporate flu shots can also help prevent injuries. Employees who continue to complete their regular tasks when they have the flu are at a higher risk of injury due to 20-40% slower reaction times.

Apart from becoming ill, having influenza can be a big inconvenience. People can miss time from work because either they are too sick to attend or they have to take time off to care for a sick child. One study has shown that parents of children under 3 years of age missed an average of 3 days of work to stay home and care for their sick child.

Still have questions about the flu vaccination?

Check out our Frequently Asked Questions about Flu Shots page to learn more about the flu vaccination and the service we can provide for you.

How effective is the flu vaccine?

Clinical trials results reflect that the influenza vaccine has been shown to be 70% more effective in protecting against the severe effects of infection in healthy adults.

The Australian flu vaccine 2023

Each year the World Health Organization (WHO) puts forward its recommendations for the composition of the influenza virus vaccines.

In 2023, the Australian Influenza Vaccine Committee (AIVC) recommended the following viruses for the 2023 southern hemisphere season quadrivalent influenza vaccines:

Egg-based quadrivalent influenza vaccines:

• an A/Sydney/5/2021 (H1N1)pdm09-like virus;
• an A/Darwin/9/2021 (H3N2)-like virus;
• a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and
• a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.

Cell- or recombinant-based quadrivalent influenza vaccines:

• an A/Sydney/5/2021 (H1N1)pdm09-like virus;
• an A/Darwin/6/2021 (H3N2)-like virus;
• a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and
• a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.

For more detailed information, review the specific recommendations from the AIVC.